Cargando…

Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease

INTRODUCTION: (18)F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is commonly used to estimate neuronal injury in Alzheimer's disease (AD). Here, we evaluate the utility of dynamic PET measures of perfusion using (11)C-Pittsburgh compound B (PiB) to estimate neuronal injury in com...

Descripción completa

Detalles Bibliográficos
Autores principales:	Joseph-Mathurin, Nelly, Su, Yi, Blazey, Tyler M., Jasielec, Mateusz, Vlassenko, Andrei, Friedrichsen, Karl, Gordon, Brian A., Hornbeck, Russ C., Cash, Lisa, Ances, Beau M., Veale, Thomas, Cash, David M., Brickman, Adam M., Buckles, Virginia, Cairns, Nigel J., Cruchaga, Carlos, Goate, Alison, Jack, Clifford R., Karch, Celeste, Klunk, William, Koeppe, Robert A., Marcus, Daniel S., Mayeux, Richard, McDade, Eric, Noble, James M., Ringman, John, Saykin, Andrew J., Thompson, Paul M., Xiong, Chengjie, Morris, John C., Bateman, Randall J., Benzinger, Tammie L.S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Neuroimaging
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215983/ https://www.ncbi.nlm.nih.gov/pubmed/30417072 http://dx.doi.org/10.1016/j.dadm.2018.08.012

Ejemplares similares

Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
por: Su, Yi, et al.
Publicado: (2016)

Correction: Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer’s Disease: Results from the DIAN Study Group
por: Su, Yi, et al.
Publicado: (2016)

Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
por: Su, Yi, et al.
Publicado: (2018)

Discovery and validation of autosomal dominant Alzheimer’s disease mutations
por: Hsu, Simon, et al.
Publicado: (2018)

Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease
por: Schultz, Stephanie A., et al.
Publicado: (2020)

T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease
por: Rahmani, Farzaneh, et al.
Publicado: (2023)

Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease
por: Joseph-Mathurin, Nelly, et al.
Publicado: (2021)

Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology
por: Gordon, Brian A., et al.
Publicado: (2018)

Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [(18)F]flortaucipir study
por: O’Connor, Antoinette, et al.
Publicado: (2023)

Weakly activated core inflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2021)

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer disease: a longitudinal study
por: Gordon, Brian A., et al.
Publicado: (2018)

Weakly activated core neuroinflammation pathways were identified as a central signaling mechanism contributing to the chronic neurodegeneration in Alzheimer’s disease
por: Li, Fuhai, et al.
Publicado: (2022)

Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function
por: Su, Yi, et al.
Publicado: (2015)

Neurological Manifestations of Autosomal Dominant Alzheimer’s Disease from the DIAN cohort and a meta-analysis
por: Tang, Mengxuan, et al.
Publicado: (2016)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer’s disease
por: Lee, Seonjoo, et al.
Publicado: (2018)

Brain aerobic glycolysis and resilience in Alzheimer disease
por: Goyal, Manu S., et al.
Publicado: (2023)

Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2018)

Persistent metabolic youth in the aging female brain
por: Goyal, Manu S., et al.
Publicado: (2019)

Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease
por: Dincer, Aylin, et al.
Publicado: (2020)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2019)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
por: Wang, Guoqiao, et al.
Publicado: (2019)

Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies
por: Su, Yi, et al.
Publicado: (2019)

Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN)
por: McKay, Nicole S., et al.
Publicado: (2023)

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease
por: Müller, Stephan, et al.
Publicado: (2017)

Quantitative Analysis of PiB-PET with FreeSurfer ROIs
por: Su, Yi, et al.
Publicado: (2013)

Baseline Microglial Activation Correlates With Brain Amyloidosis and Longitudinal Cognitive Decline in Alzheimer Disease
por: Wang, Qing, et al.
Publicado: (2022)

Expression of Novel Alzheimer’s Disease Risk Genes in Control and Alzheimer’s Disease Brains
por: Karch, Celeste M., et al.
Publicado: (2012)

A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease
por: Grill, Joshua D., et al.
Publicado: (2015)

Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer’s disease
por: Vermunt, Lisa, et al.
Publicado: (2020)

Comparison of the Ekblom-Bak Submaximal Test to a Maximal Test in a Cohort of Healthy Younger and Older Adults in the United States
por: Schultz, Stephanie A., et al.
Publicado: (2020)

First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer’s disease: the Dominantly Inherited Alzheimer’s Network Study
por: O'Connor, Antoinette, et al.
Publicado: (2023)

Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
por: Bollinger, Rebecca M, et al.
Publicado: (2021)

The pattern of atrophy in familial Alzheimer disease: Volumetric MRI results from the DIAN study
por: Cash, David M., et al.
Publicado: (2013)

Characterizing the Role of Brain Derived Neurotrophic Factor Genetic Variation in Alzheimer’s Disease Neurodegeneration
por: Honea, Robyn A., et al.
Publicado: (2013)

Predicting sporadic Alzheimer’s disease progression via inherited Alzheimer’s disease-informed machine-learning
por: Franzmeier, Nicolai, et al.
Publicado: (2020)

Flortaucipir (tau) PET in LGI1 antibody encephalitis
por: Day, Gregory S., et al.
Publicado: (2021)

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
por: Brier, Matthew R., et al.
Publicado: (2016)

African Americans Have Differences in CSF Soluble TREM2 and Associated Genetic Variants
por: Schindler, Suzanne E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ag51dvq2olr1aehfm5cpiievf7